Financial statements Interferon

Balance sheet of Interferon

Company age:
Age:
5 y. 5 m. 24 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of INTERFERON

Year
2020
2021
2022
2023
Total assets 103 110,63 498 341,91 1 550 656,68 1 343 768,07
A. Fixed assets - 275 541,30 275 541,30 0,00
B. Current assets 103 110,63 222 800,61 1 275 115,38 1 343 768,07
C. Share capital contributions (basic funds) - - 0,00 -
D. Own shares (stocks) - - 0,00 -
Total liabilities 103 110,63 498 341,91 1 550 656,68 1 343 768,07
A. Equity 82 789,63 191 947,27 884 359,28 965 218,89
B. Liabilities and provisions for liabilities 20 321,00 306 394,64 666 297,40 378 549,18
I. Long-term liabilities - - - -
II. Short-term liabilities - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.